https://www.linkedin.com/company/homology-medicines-inc./
Recent FIXX News
- Homology Medicines Declares Distribution to Common Stockholders • GlobeNewswire Inc. • 03/18/2024 08:30:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/11/2024 11:37:28 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 11:32:56 AM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 02/21/2024 09:04:56 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/15/2024 05:15:36 AM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 02/13/2024 03:11:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 10:54:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 10:49:06 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 01/03/2024 09:29:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 09:26:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:15:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:15:15 PM
- Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency • GlobeNewswire Inc. • 01/03/2024 09:08:55 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 09:05:19 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/16/2023 09:19:25 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/16/2023 09:16:27 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/16/2023 09:13:55 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/16/2023 12:46:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 12:45:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/16/2023 12:17:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 12:16:09 PM
- Q32 Bio and Homology Medicines Announce Merger Agreement • GlobeNewswire Inc. • 11/16/2023 12:05:00 PM
- Q32 Bio and Homology Medicines Announce Merger Agreement • PR Newswire (US) • 11/16/2023 12:05:00 PM
- Homology Medicines Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/14/2023 09:33:57 PM
FEATURED Mawson Finland Provides Update on Exploration Activities at Rajapalot • Aug 21, 2024 9:06 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM